- Home
- HOUR vs ARTV Comparison
HOUR vs ARTV Comparison
Compare HOUR & ARTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOUR
- ARTV
- Stock Information
- Founded
- HOUR 2015
- ARTV 2019
- Country
- HOUR United States
- ARTV United States
- Employees
- HOUR N/A
- ARTV N/A
- Industry
- HOUR Catalog/Specialty Distribution
- ARTV
- Sector
- HOUR Consumer Discretionary
- ARTV
- Exchange
- HOUR Nasdaq
- ARTV NYSE
- Market Cap
- HOUR 47.1M
- ARTV 39.0M
- IPO Year
- HOUR 2022
- ARTV 2024
- Fundamental
- Price
- HOUR $1.61
- ARTV $2.04
- Analyst Decision
- HOUR
- ARTV Strong Buy
- Analyst Count
- HOUR 0
- ARTV 8
- Target Price
- HOUR N/A
- ARTV $18.14
- AVG Volume (30 Days)
- HOUR 427.9K
- ARTV 366.6K
- Earning Date
- HOUR 08-08-2025
- ARTV 08-28-2025
- Dividend Yield
- HOUR N/A
- ARTV N/A
- EPS Growth
- HOUR N/A
- ARTV N/A
- EPS
- HOUR 0.01
- ARTV N/A
- Revenue
- HOUR $139,408,829.00
- ARTV N/A
- Revenue This Year
- HOUR N/A
- ARTV N/A
- Revenue Next Year
- HOUR N/A
- ARTV N/A
- P/E Ratio
- HOUR $234.09
- ARTV N/A
- Revenue Growth
- HOUR 2.71
- ARTV N/A
- 52 Week Low
- HOUR $0.83
- ARTV $1.47
- 52 Week High
- HOUR $6.90
- ARTV $17.31
- Technical
- Relative Strength Index (RSI)
- HOUR 62.63
- ARTV N/A
- Support Level
- HOUR $1.46
- ARTV N/A
- Resistance Level
- HOUR $1.74
- ARTV N/A
- Average True Range (ATR)
- HOUR 0.17
- ARTV 0.00
- MACD
- HOUR 0.02
- ARTV 0.00
- Stochastic Oscillator
- HOUR 35.59
- ARTV 0.00
About HOUR Hour Loop Inc.
Hour Loop Inc is a technology-enabled consumer products company that uses machine learning and data analytics to design, develop, market, and sell products. Hour Loop predominantly operates through online retail channels such as Amazon, Walmart, and Hourloop.com. The Company, as an Internet marketplace seller, sells products in multiple categories, including home/garden decor, toys, kitchenware, apparel, and electronics. It has only one segment, which is online retail (e-commerce).
About ARTV ARTIVA BIOTHERAPEUTICS INC
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).